Mercury-added medicines bringing significant health benefits and in which mercury as an active substance cannot be substituted should not be subject to ban, as it is already the case under Regulation 1102/2008.
Zdravila z dodanim živim srebrom, ki prinašajo znatne zdravstvene koristi in pri katerih živega srebra kot zdravilne učinkovine ni mogoče nadomestiti, se ne bi smela prepovedati, kot že velja v skladu z Uredbo 1102/2008.